New study reveals health risks associated with transgender women's hormone therapy
Transgender women face a litany of health risks in modern society — and a new study published this week reveals that there may be one more to add to the list.
The study, conducted by Kaiser Permanente, examined the medical history of 5,000 transgender patients over the course of eight years. It is the largest research project dealing with transgender people on hormone replacement therapy (HRT) ever conducted, NBC News reports. Comparing the data of transgender patients to that of over 97,000 cisgender patients, the study suggests that there may be a correlation between hormone therapy and an increased risk of "cardiovascular problems," including stroke, heart attack, and blood clots.
"Doctors and patients need to be aware of the possibility for increased health risks for transgender women," said Dr. Darios Getahun, one of the authors of the study, which was published Tuesday in the journal Annals of Internal Medicine. A similar risk was not identified for transgender men on hormone therapy. The study is, admittedly, not perfect, as Getahun cautioned that "direct cause and effect" would be difficult to prove; to conduct a traditional study, transgender women would have to be given placebo hormones without their knowledge or consent, which presents an ethical problem.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Still, the study is leaps ahead of older research on transgender women. Previous studies on hormone therapy have simply researched cisgender women going through menopause, and applied those findings to trans women, but this study found significant differences between the two groups.
Even with the results, the study authors predict transgender women would take the gamble. "I think most transgender women would conclude the risk is not high enough to forgo hormone therapy," said Dr. Joshua Safer, executive director of the Transgender Medicine Center at Mount Sinai Hospital in New York and study co-author. "The risks here are not different from many other medications and therapies that are used."
Read more at NBC News.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Shivani is the editorial assistant at TheWeek.com and has previously written for StreetEasy and Mic.com. A graduate of the physics and journalism departments at NYU, Shivani currently lives in Brooklyn and spends free time cooking, watching TV, and taking too many selfies.
-
Is the next cold war a drone-swarm race between US and China?
Today's Big Question Both global superpowers are building up their capacity for surging robotic warfare. What happens next is anyone's guess.
By Rafi Schwartz, The Week US Published
-
Crossword: April 17, 2024
The Week's daily crossword
By The Week Staff Published
-
Sudoku hard: April 17, 2024
The Week's daily hard sudoku puzzle
By The Week Staff Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
How happy is Finland really?
Today's Big Question Nordic nation tops global happiness survey for seventh year in a row with 'focus on contentment over joy'
By Harriet Marsden, The Week UK Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
How Tehran became the world's nose job capital
Under the radar Iranian doctors raise alarm over low costs, weak regulation and online influence of 'Western beauty standards'
By Harriet Marsden, The Week UK Published
-
Africa's renewed battle against female genital mutilation
Under the radar Campaigners call for ban in Sierra Leone after deaths of three girls as coast-to-coast convoy prepares to depart
By Harriet Marsden, The Week UK Published
-
Argentina: the therapy capital of the world
Under the radar Buenos Aires natives go hungry to pay for psychoanalysis, amid growing instability, anxiety – and societal acceptance
By Harriet Marsden, The Week UK Published
-
Does declining birth rate spell doom for Britain?
Today's Big Question Ageing population puts pressure on welfare state, economy and fabric of society, while fertility is rising on populist agendas
By Harriet Marsden, The Week UK Published